Bayer Turns To Digital Health To ‘Reach All Aspects Of Drug Development Spectrum’
This article was originally published in Clinica
Executive Summary
An app for improving medication compliance, a vitamin levels analyzer and a hormone tracker – these are just some of the digital health technologies that caught the eye of pharma giant Bayer Healthcare in the second edition of its "Grants4Apps" program. The initiative aims to offer financial support and business expertise to digital health start-up companies – an area of development it describes as a "very vibrant."
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.